日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumour-reactive heterotypic CD8 T cell clusters from clinical samples

临床样本中的肿瘤反应性异型CD8 T细胞簇

Sofía Ibáñez-Molero #,Johanna Veldman #,Juan Simon Nieto,Joleen J H Traets,Austin George,Kelly Hoefakker,Anita Karomi,Rolf Harkes,Bram van den Broek,Su Min Pack,Liselotte Tas,Nils L Visser,Susan E van Hal-van Veen,Paula Alóndiga-Mérida,Maartje Alkemade,Iris M Seignette,Renaud Tissier,Marja Nieuwland,Martijn van Baalen,Joanna Poźniak,Erik Mul,Simon Tol,Sofia Stenqvist,Lisa M Nilsson,Jonas A Nilsson,John B A G Haanen,Winan J van Houdt,Daniel S Peeper

Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers

胞苷二磷酸二酰甘油合酶2是间质样癌症中的合成致死靶点

Tim Arnoldus ,Alex van Vliet ,Onno B Bleijerveld ,Adriaan F H de Groot ,Qinglin Piao ,Niek Blomberg ,Désirée Schatton ,Jing Dong ,Susan E van Hal-van Veen ,Rolf Harkes ,Anita E Grootemaat ,Natalie Proost ,Birol Cabukusta ,Christian Frezza ,Marieke van de Ven ,Nicole N van der Wel ,Martin Giera ,Maarten Altelaar ,Daniel S Peeper

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

非小细胞肺癌免疫治疗耐药机制分类:我们如何才能做得更好?

van der Geest, Daphne; van Vliet, Alex; Peeper, Daniel S; Haanen, John B A G; Smit, Egbert F; Theelen, Willemijn S M E

TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors

TRAF2 和 RIPK1 重复介导 TNFR1 和 CD95 型死亡受体的经典 NFκB 信号传导

Jennifer Wagner, David Vredevoogd, Xin Yu, Dong Lu, Daniel S Peeper, Heike M Hermanns, Jin Wang, Harald Wajant, Daniela Siegmund

Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing

抑制TBK1/IKKε介导的RIPK1磷酸化可增强肿瘤对免疫细胞杀伤的敏感性

Piskopou, Anastasia; Vredevoogd, David W; Kong, Xiangjun; Peeper, Daniel S; Altelaar, Maarten; Stecker, Kelly E

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness

多模式刺激筛选揭示了限制T细胞适应性的独特和共有基因

Chun-Pu Lin,Pierre L Levy,Astrid Alflen,Georgi Apriamashvili,Maarten A Ligtenberg,David W Vredevoogd,Onno B Bleijerveld,Ferhat Alkan,Yuval Malka,Liesbeth Hoekman,Ettai Markovits,Austin George,Joleen J H Traets,Oscar Krijgsman,Alex van Vliet,Joanna Poźniak,Carlos Ariel Pulido-Vicuña,Beaunelle de Bruijn,Susan E van Hal-van Veen,Julia Boshuizen,Pim W van der Helm,Judit Díaz-Gómez,Hamdy Warda,Leonie M Behrens,Paula Mardesic,Bilal Dehni,Nils L Visser,Jean-Christophe Marine,Gal Markel,William J Faller,Maarten Altelaar,Reuven Agami,Michal J Besser,Daniel S Peeper

Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer

化疗药物和亮氨酸剥夺会诱导癌症中密码子偏向的异常蛋白质产生

Adva Kochavi, Remco Nagel, Pierre-Rene Körner, Onno B Bleijerveld, Chun-Pu Lin, Zowi Huinen, Yuval Malka, Natalie Proost, Marieke van de Ven, Xiaodong Feng, Jasmine Montenegro Navarro, Abhijeet Pataskar, Daniel S Peeper, Julien Champagne, Reuven Agami

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

TMED抑制剂可抑制细胞表面PD-1表达并克服T细胞功能障碍

Vredevoogd, David W; Apriamashvili, Georgi; Levy, Pierre L; Sinha, Sanju; Huinen, Zowi R; Visser, Nils L; de Bruijn, Beaunelle; Boshuizen, Julia; van Hal-van Veen, Susan E; Ligtenberg, Maarten A; Bleijerveld, Onno B; Lin, Chun-Pu; Díaz-Gómez, Judit; Sánchez, Santiago Duro; Markovits, Ettai; Simon Nieto, Juan; van Vliet, Alex; Krijgsman, Oscar; Markel, Gal; Besser, Michal J; Altelaar, Maarten; Ruppin, Eytan; Peeper, Daniel S

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

作者更正:逆转预先存在的NGFR驱动的肿瘤和免疫疗法耐药性

Boshuizen, Julia; Vredevoogd, David W; Krijgsman, Oscar; Ligtenberg, Maarten A; Blankenstein, Stephanie; de Bruijn, Beaunelle; Frederick, Dennie T; Kenski, Juliana C N; Parren, Mara; Brüggemann, Marieke; Madu, Max F; Rozeman, Elisa A; Song, Ji-Ying; Horlings, Hugo M; Blank, Christian U; van Akkooi, Alexander C J; Flaherty, Keith T; Boland, Genevieve M; Peeper, Daniel S

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

IFN-γ 特征可用于选择 III 期黑色素瘤患者的新辅助治疗方案

Irene L M Reijers # ,Disha Rao # ,Judith M Versluis ,Alexander M Menzies ,Petros Dimitriadis ,Michel W Wouters ,Andrew J Spillane ,Willem M C Klop ,Annegien Broeks ,Linda J W Bosch ,Marta Lopez-Yurda ,Winan J van Houdt ,Robert V Rawson ,Lindsay G Grijpink-Ongering ,Maria Gonzalez ,Sten Cornelissen ,Jasper Bouwman ,Joyce Sanders ,Elsemieke Plasmeijer ,Yannick S Elshot ,Richard A Scolyer ,Bart A van de Wiel ,Daniel S Peeper ,Alexander C J van Akkooi ,Georgina V Long ,Christian U Blank